HomeMRKR • NASDAQ
add
Marker Therapeutics Inc
Previous close
$4.01
Day range
$3.78 - $3.94
Year range
$1.57 - $9.68
Market cap
34.52M USD
Avg Volume
10.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 1.24M | 0.79% |
Operating expense | 3.79M | 75.01% |
Net income | -2.39M | 51.83% |
Net profit margin | -192.34 | 52.21% |
Earnings per share | -0.27 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.32M | 76.89% |
Total assets | 14.09M | -49.57% |
Total liabilities | 2.30M | -80.85% |
Total equity | 11.79M | — |
Shares outstanding | 8.92M | — |
Price to book | 3.04 | — |
Return on assets | -40.82% | — |
Return on capital | -49.32% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.39M | 51.83% |
Cash from operations | -3.84M | 34.83% |
Cash from investing | — | — |
Cash from financing | 49.10K | -92.08% |
Net change in cash | -3.79M | 29.60% |
Free cash flow | -3.12M | 18.05% |
About
Founded
1992
Headquarters
Website
Employees
8